JP2013230157A5 - - Google Patents

Download PDF

Info

Publication number
JP2013230157A5
JP2013230157A5 JP2013139604A JP2013139604A JP2013230157A5 JP 2013230157 A5 JP2013230157 A5 JP 2013230157A5 JP 2013139604 A JP2013139604 A JP 2013139604A JP 2013139604 A JP2013139604 A JP 2013139604A JP 2013230157 A5 JP2013230157 A5 JP 2013230157A5
Authority
JP
Japan
Prior art keywords
composition
use according
pharmaceutical composition
dosage form
tag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013139604A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013230157A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013230157A publication Critical patent/JP2013230157A/ja
Publication of JP2013230157A5 publication Critical patent/JP2013230157A5/ja
Pending legal-status Critical Current

Links

JP2013139604A 2003-03-07 2013-07-03 IgA1沈着症の治療 Pending JP2013230157A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45305503P 2003-03-07 2003-03-07
US60/453,055 2003-03-07

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010270964A Division JP2011101645A (ja) 2003-03-07 2010-12-03 IgA1沈着症の治療

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015024975A Division JP2015096079A (ja) 2003-03-07 2015-02-12 IgA1沈着症の治療

Publications (2)

Publication Number Publication Date
JP2013230157A JP2013230157A (ja) 2013-11-14
JP2013230157A5 true JP2013230157A5 (enExample) 2013-12-26

Family

ID=33418058

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2006509132A Expired - Lifetime JP5438886B2 (ja) 2003-03-07 2004-03-05 IgA1沈着症の治療
JP2010270964A Withdrawn JP2011101645A (ja) 2003-03-07 2010-12-03 IgA1沈着症の治療
JP2013139604A Pending JP2013230157A (ja) 2003-03-07 2013-07-03 IgA1沈着症の治療
JP2015024975A Pending JP2015096079A (ja) 2003-03-07 2015-02-12 IgA1沈着症の治療

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2006509132A Expired - Lifetime JP5438886B2 (ja) 2003-03-07 2004-03-05 IgA1沈着症の治療
JP2010270964A Withdrawn JP2011101645A (ja) 2003-03-07 2010-12-03 IgA1沈着症の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015024975A Pending JP2015096079A (ja) 2003-03-07 2015-02-12 IgA1沈着症の治療

Country Status (10)

Country Link
US (3) US7407653B2 (enExample)
EP (1) EP1603511B1 (enExample)
JP (4) JP5438886B2 (enExample)
KR (2) KR20130026513A (enExample)
CN (1) CN1777673B (enExample)
AT (1) ATE496992T1 (enExample)
CA (1) CA2558873C (enExample)
DE (1) DE602004031199D1 (enExample)
ES (1) ES2360291T3 (enExample)
WO (1) WO2004096157A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130026513A (ko) 2003-03-07 2013-03-13 뉴 잉글랜드 메디컬 센터 호스피털스 인코퍼레이티드 IgA1 침착 질환 치료
US8440191B2 (en) 2005-11-18 2013-05-14 Tufts Medical Center Clearance of abnormal IGA1 in IGA1 deposition diseases
US20080027554A1 (en) * 2006-07-31 2008-01-31 Talmadge Karen D Kit and methods of treatment of an intervertebral disc
US20100261252A1 (en) * 2009-04-10 2010-10-14 Biomarin Pharmaceutical Inc. Methods of enhancing yield of active iga protease
WO2010123885A2 (en) * 2009-04-20 2010-10-28 Tufts Medical Center, Inc. Iga1 protease polypeptide agents and uses thereof
CN104073474A (zh) * 2014-06-27 2014-10-01 樊均明 一种IgA1酶及其制备方法和应用
US20170369551A1 (en) * 2016-06-24 2017-12-28 Anthera Pharmaceuticals, Inc. METHODS OF TREATING IgA NEPHROPATHY AND HENOCH-SCHONLEIN PURPURA NEPHRITIS USING A B-CELL ACTIVATING FACTOR (BAFF) INHIBITOR
CN115197328B (zh) * 2021-04-09 2025-05-16 北京大学第一医院 一种可清除体内免疫球蛋白A的重组融合蛋白酶及其制备方法和在治疗IgA肾病中的应用
US20250242002A1 (en) * 2022-01-29 2025-07-31 Peking University First Hospital Truncated forms of iga protease, fusion proteins comprising a truncated form of iga protease and uses thereof
KR20250114034A (ko) 2022-11-11 2025-07-28 아이간 바이오사이언스 Iga 프로테아제 폴리펩타이드 제제
WO2025183146A1 (ja) * 2024-02-29 2025-09-04 積水メディカル株式会社 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、免疫学的測定用試薬キット、及び非特異反応抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
ATE396399T1 (de) * 1998-03-31 2008-06-15 Asahi Kasei Pharma Corp Verfahren zur untersuchung der iga-nephropathie
DK2067788T3 (da) 1999-05-18 2015-10-19 Dyax Corp Fab-fragmentbiblioteker og fremgangsmåder til anvendelse deraf
KR20130026513A (ko) * 2003-03-07 2013-03-13 뉴 잉글랜드 메디컬 센터 호스피털스 인코퍼레이티드 IgA1 침착 질환 치료

Similar Documents

Publication Publication Date Title
JP2013230157A5 (enExample)
JP2012144538A5 (enExample)
TWD179359S (zh) 藥物注射裝置之部分(五)
IL235020A0 (en) History of n-phenylbenzenesulfonamide, pharmaceutical preparations containing them and their use in the preparation of medicines
MX2015010083A (es) Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos.
WO2015048498A3 (en) Carrier-free biologically-active protein nanostructures
HK1218392A1 (zh) 抗篡改的药物制剂
JP2011516606A5 (enExample)
PH12015500374A1 (en) Extended release compositions of an aminoalkyl nitrate
JP2016528283A5 (enExample)
PH12015501313A1 (en) Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration
WO2011093814A3 (en) A pharmaceutical combination comprising formoterol and ciclesonide
MX2011005899A (es) Composicion farmacéutica con antihistamínico no sedante y combinaciones.
CN302482374S (zh) 药品包装盒(头孢克洛颗粒)
CN302041178S (zh) 瓶体
UA100374C2 (ru) Лекарственное средство в виде порошка в саше с муколитическими и отхаркивающими свойствами
Woo et al. Life Science: RESEARCH ARTICLE; Development of sildenafil-loaded orally disintegrating tablet with new lactate salt
CN302199354S (zh) 药瓶(顺妥敏)
CN302482372S (zh) 药品包装盒(注射用盐酸丙帕他莫)
CN302121186S (zh) 药品包装盒(克比热提片)
TR201005911A2 (tr) Geliştirilmiş dissolüsyon profiline sahip bir ilaç formülasyonu.
RU2012126428A (ru) Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в альбумине человеческом сывороточном
CN302412321S (zh) 药盒(三维b片)
CN302230035S (zh) 药品包装盒(曲安奈德鼻喷雾剂1)
CN302230034S (zh) 药品包装盒(曲安奈德鼻喷雾剂2)